[
  {
    "ts": "2025-04-29T11:00:00+00:00",
    "headline": "ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy",
    "summary": "ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G-Rex® Grant will be used to advance the manufacturing of their lead asset, MB-105, a novel investigational autologous CAR-T cell therapy targeting CD5 for patients with T-cell lymphomas.",
    "url": "https://finance.yahoo.com/news/scaleready-announces-march-biosciences-recipient-110000510.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "85993b09-0349-3890-9612-cc88e41122ca",
      "content": {
        "id": "85993b09-0349-3890-9612-cc88e41122ca",
        "contentType": "STORY",
        "title": "ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy",
        "description": "",
        "summary": "ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G-Rex® Grant will be used to advance the manufacturing of their lead asset, MB-105, a novel investigational autologous CAR-T cell therapy targeting CD5 for patients with T-cell lymphomas.",
        "pubDate": "2025-04-29T11:00:00Z",
        "displayTime": "2025-04-29T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f40b47f33eddd4c054e052bdc085a357",
          "originalWidth": 400,
          "originalHeight": 207,
          "caption": "ScaleReady Logo (PRNewsfoto/Bio-Techne Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc0A61Mwv2SkgNPhWQQstA--~B/aD0yMDc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f40b47f33eddd4c054e052bdc085a357.cf.webp",
              "width": 400,
              "height": 207,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CH_8muO0znaSDXNp280njg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f40b47f33eddd4c054e052bdc085a357.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/scaleready-announces-march-biosciences-recipient-110000510.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/scaleready-announces-march-biosciences-recipient-110000510.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]